Maria Sibilia

16PUBLICATIONS
100CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityEnvironmental epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 11, 2026
Absence of EGFR signalling in granulocytic cells relieves immunosuppression sensitising CRC metastases to immune checkpoint therapy.

|Jun 02, 2026
EGFR deletion in myeloid cells reprograms the immunosuppressive landscape of colorectal cancer.

|Apr 13, 2026
Improved Systemic Immunochemotherapy Employing an Oxaliplatin-TLR7/8 Agonist Prodrug Strategy.

Michael Gutmann, Martijn Dijkstra, Philipp Salomon

|Sep 24, 2025
TYK2 Promotes Immunosurveillance of Colorectal Cancer Liver Metastasis.

Bernadette Mödl, Daniela Zwolanek, Katharina Schwertner

|May 06, 2025
EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer.

Dana Krauß, Veronica Moreno-Viedma, Emi Adachi-Fernandez

|Jan 23, 2025
Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells.

Martina Sanlorenzo, Philipp Novoszel, Igor Vujic

Pageof 3

Frequent Collaborators

5 joint publications

Dana Krauss

4 joint publications

Martin Holcmann

3 joint publications

Matthias Farlik

3 joint publications

Lukas Kenner